(Q70168072)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

main subject

metastatic breast cancer

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

author name string

P Jakobsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

E Steiness

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

M Dalmark

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

A Lorenzen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

D Petersen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

S B Gjedde

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

E Sandberg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

C Rose

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

O S Nielsen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

63-68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00684959

9 October 2019

exact match

0 references

cites work

Age dependence of the early-phase pharmacokinetics of doxorubicin

1 reference

12 December 2020

Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over study.

1 reference

12 December 2020

Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans

1 reference

12 December 2020

When can the infusion period be safely ignored in the estimation of pharmacokinetic parameters of drugs in humans?

1 reference

12 December 2020

Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administration.

1 reference

12 December 2020

Time dependency of adriamycin and adriamycinol kinetics

1 reference

12 December 2020

Pharmacokinetics and metabolism of epirubicin during repetitive courses of administration in Hodgkin's patients

1 reference

12 December 2020

Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer

1 reference

12 December 2020

Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial

1 reference

12 December 2020

Sensitive and specific determination of the new anthracycline analog 4'-epidoxorubicin and its metabolites by high pressure liquid chromatography

1 reference

12 December 2020

Separation, characterization, and analysis of epirubicin (4'-epidoxorubicin) and its metabolites from human urine

1 reference

12 December 2020

Epirubicin plasma and blood pharmacokinetics after single i.v. bolus in advanced cancer patients.

1 reference

12 December 2020

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.

1 reference

12 December 2020

A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00684959

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040035%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference